Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools

Cheng Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Cheng Li | Drug Delivery Systems | Best Researcher Award

Profess at Shanghai Fourth People’s Hospital | School of Medicine | Tongji Universit | China

Prof. Cheng Li  is a distinguished chief physician, professor, and doctoral supervisor in anesthesiology. A visiting scholar at Harvard University , he directs a National Key Clinical Specialty and serves as a leading researcher at the Shanghai Key Laboratory of Anesthesia and Brain Function Regulation . Prof. Li has pioneered 11 innovative technologies enhancing elderly critical care and brain protection . His prolific academic, clinical, and mentorship contributions have earned him national recognition . Dedicated to advancing anesthesia and perioperative science, Prof. Li is shaping the future of surgical medicine through groundbreaking innovation and academic excellence.

Profile 

Scopus

Education

Prof. Cheng Li completed his medical education from top-tier Chinese medical institutions . His rigorous academic training in anesthesiology and perioperative medicine laid the foundation for his specialization in critical care for elderly patients and neurological function regulation . He further enhanced his expertise as a visiting scholar at Harvard University , gaining international exposure and experience. As a committed academician, he continues to mentor postgraduate and doctoral students . Prof. Li’s comprehensive education, both domestic and abroad, has equipped him with deep clinical insight, strong research methodology skills, and a global perspective on patient care .

Experience 

Prof. Li Cheng has over two decades of clinical and research experience in anesthesiology and perioperative medicine . He serves as the Director of a National Key Clinical Specialty and leads a research team at the Shanghai Key Laboratory of Anesthesia and Brain Function Regulation . He is actively involved in hospital technology adoption and has led the development of 11 technologies for elderly and critically ill patients . Prof. Li holds more than 20 academic positions and has supervised 24 postdoctoral, Ph.D., and master’s students . He continues to impact both policy and practice in Chinese medical institutions .

Awards 

Prof. Cheng Li has received numerous prestigious awards recognizing his academic and clinical excellence. These include Shanghai Outstanding Academic Leader, Shanghai Young Top Talent, and the Third Prize of the Shanghai Silver Snake Award. He was named “China’s Good Doctor”, the First Shanghai Good Doctor, and received the Outstanding Young Medical Talent – “Medical Star of Shanghai”. In 2022, he was honored as the “Outstanding Teacher of the Most Beautiful Professional Ethics” by Tongji University. His team has earned collective honors such as the Advanced Collective of the National Health and Wellness System.

Research Focus 

Prof. Li’s research is centered on anesthesia and perioperative management in elderly and critically ill patients. His work on brain protection and neurological regulation has led to 11 innovative clinical technologies. He is actively exploring biomarker-based monitoring, neuro-anesthetic pharmacology, and personalized anesthesia protocols in surgical settings. His involvement in intraoperative brain function control, post-operative cognitive disorder prevention, and advanced anesthesia devices underscores his commitment to translational medicine. Prof. Li’s research integrates clinical expertise with cutting-edge science to elevate surgical safety and efficiency, especially for high-risk elderly patients.

Publication Top Notes

Title: Three-stage sequential targeted nasal drops for correcting abnormal mitochondrial division in microglia
Journal: Bioactive Materials
Year: 2025

Title: Lactate inhibits T-cell activation in sepsis through CD40LG downregulation and SOCS3-mediated JAK1/STAT3 pathway suppression
Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
Year: 2025

Title: Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation
Journal: [Journal name not specified]
Year: 2025
Cited by: 1

Title: Thermo-responsive and biodegradable MoS2-based nanoplatform for tumor therapy and postoperative wound management
Journal: Journal of Colloid and Interface Science
Year: 2025
Cited by: 2

Title: Disrupting the activity of endogenous gas neurotransmitters: a therapeutic strategy using engineered metal–organic frameworks for cancer
Journal: Medical Gas Research
Year: 2025

Conclusion

In conclusion, Prof. Cheng Li’s impactful innovations, prolific research output, and exceptional leadership in anesthesiology make him a highly deserving candidate for the Best Researcher Award. His clinical and academic contributions have significantly advanced patient care and scientific knowledge in anesthesiology, earning national recognition and academic prestige. With ongoing focus and minor enhancements in international outreach and interdisciplinary integration, he stands poised to further shape the global landscape of perioperative and critical care research.